Dapagliflozin After Transcatheter Aortic Valve Implantation

PHASE4CompletedINTERVENTIONAL
Enrollment

1,257

Participants

Timeline

Start Date

January 27, 2021

Primary Completion Date

December 29, 2024

Study Completion Date

December 30, 2024

Conditions
Aortic StenosisTranscatether Aortic Valve Implantation
Interventions
DRUG

Dapagliflozin 10 MG

Dapagliflozin 10 mg (daily oral dose)

Trial Locations (40)

Unknown

Hospital Juan Canalejo, A Coruña

Hospital Universitario de Albacete, Albacete

Hospital General Universitario de Alicante, Alicante

Hospital Universitario de Cruces, Barakaldo

Centro Médico TEKNON, Barcelona

Hospital Clinic, Barcelona

Hospital de Bellvitge, Barcelona

Hospital German I Trias, Barcelona

Hospital Universitario Sant Pau, Barcelona

Hospital Universitario Vall D´Hebron, Barcelona

Hospital Puerta Del Mar, Cadiz

Hospital Reina Sofia, Córdoba

Hospital San Cecilio, Granada

Hospital Virgen de Las Nieves, Granada

Hospital Juan Ramón Jiménez, Huelva

Hospital Universitario de Jaen, Jaén

Hospital Universitario de León, León

Clinica La Luz, Madrid

Clinica Nuestra Señora de América de Madrid, Madrid

Fundación Jimenez Diaz, Madrid

Hospital 12 de Octubre, Madrid

Hospital Clínico San Carlos, Madrid

Hospital La Princesa, Madrid

Hospital Puerta de Hierro, Madrid

Hospital Ramón Y Cajal, Madrid

Hospital Universitario de Torrejón, Madrid

Hospital Virgen de La Victoria, Málaga

Hospital Universitario Central de Asturias, Oviedo

Hospital Son Espases, Palma de Mallorca

Hospital Universitario de Navarra, Pamplona

Hospital Universitario de Salamanca, Salamanca

Hospital Universitario de Canarias, Santa Cruz de Tenerife

Hospital Marqués de Valdecilla, Santander

Hospital Clínico de Santiago, Santiago de Compostela

Hospital Virgen Del Rocio, Seville

Hospital Clínico de Valencia, Valencia

Hospital La Fe, Valencia

Hospital Clinico Universitario de Valladolid, Valladolid

Hospital Álvaro Cunqueiro, Vigo

Hospital Miguel Servet, Zaragoza

All Listed Sponsors
collaborator

Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

OTHER

lead

Spanish Society of Cardiology

OTHER

NCT04696185 - Dapagliflozin After Transcatheter Aortic Valve Implantation | Biotech Hunter | Biotech Hunter